ArticleActa pharmaceutica Sinica. B2024

Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy.

Yuzhen Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.